Abstract 2535: Development of Claudin 18.2 IHC 14G11 pharmDx as a clinical trial assay for the clinical development of anti-claudin 18.2 monoclonal antibody osemitamab (TST001) in gastric and gastroesophageal junction adenocarcinomaHayley Alderson, Emin Oroudjev, Lesly Fregoso et al.|Cancer Research|2024Cited by 2